Dong-A Socio Holdings Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dong-A Socio Holdings Co Ltd with three other
companies in this sector in South Korea:
Hanmi Pharmaceutical., Company Limited
sales of 882.72 billion Korean Won [US$827.11 million]
of which 77%
Jeil Pharma Holdings Inc
(617.28 billion Korean Won [US$578.39 million]
of which 100%
was Product sales), and
Hanmi Science Company Limited
(665.28 billion Korean Won [US$623.37 million]
of which 96%
was Pharmaceutical Sales).
Dong-A Socio Holdings Co Ltd reported sales of 726.17 billion Korean Won (US$680.42 million)
December of 2016.
increase of 3.0%
versus 2015, when the company's sales were 704.73 billion Korean Won.
This was the third consecutive year of growth at Dong-A Socio Holdings Co Ltd.
Sales of Other Segment saw an increase
that was more than double the company's growth rate: sales were up
90.6% in 2016, from
52.54 billion Korean Won to 100.12 billion Korean Won.
Dong-A Socio Holdings Co Ltd also saw significant increases in sales in
Transportation (up 12.7% to 168.20 billion Korean Won)
Glass (up 15.4% to 91.94 billion Korean Won)
Operating Consulting (up 11.1% to 52.98 billion Korean Won)
Not all segments of Dong-A Socio Holdings Co Ltd experienced an increase in sales in 2016:
sales of Pharmaceutication fell 3.2% to 485.56 billion Korean Won.